جست‌وجوی استاد و پژوهشگر

• Urology
• Prostate Cancer Diagnosis
• Bladder Cancer Treatment
• +۳ مورد دیگر

Ralph J. DeVito, MD, is an Assistant Professor of Urology at Yale School of Medicine with over 40 years of clinical experience. He specializes in endourology, prostate/bladder cancer diagnostics, renal stone disease, and benign prostatic hypertrophy (BPH). His clinical practice emphasizes minimally invasive approaches such as Artemis fusion biopsies using 3D MRI and cystoscopy. Education: BA from Hamilton College (1970), MD from Albany Medical College (1974), General Surgery residency at Hospital of St. Raphael (1974-79), and Urology residency at Yale (1979-82). Board-certified in Urology since 1984. Research interests focus on advancing prostate cancer imaging and non-invasive treatments for localized tumors. Notable contributions include work on focal therapy and MRI-guided biopsy techniques. Active in departmental leadership roles, serving on multiple committees including the Executive Committee of the Department of Urology (2013-2021). Awards: Recognized as Connecticut Best Doctors (2018-2020). Involved in institutional initiatives like the Yale Urology clinical expansion and departmental "Shark Tank" innovation competitions.

• Bladder Cancer
• Prostate Cancer
• Kidney Cancer
• +۷ مورد دیگر

Dr. Jonathan Kam is a Senior Clinical Lecturer in Urology at the University of Sydney's Sydney Medical School, affiliated with the Nepean Clinical School and the Faculty of Medicine and Health (FMH). He holds dual clinical and academic roles, specializing in urological cancers and innovative surgical techniques. His research focuses on bladder, prostate, kidney, and testicular cancers, as well as radiation-induced urological damage and reconstructive surgery. Dr. Kam completed his BMed and BSci(Med)Hons at the University of New South Wales (UNSW), graduating with distinction and earning prestigious awards including the Scientia Scholarship and UNSW Medicine Foundation Medal. He furthered his expertise through a Royal College of Surgeons Senior Clinical Fellowship at Guy’s Hospital, London, focusing on complex urological cancers. His academic roles have included positions at the University of Newcastle and UNSW, alongside research fellowships at the University of Sydney. His research has yielded over 50 peer-reviewed articles, book chapters, and case reports, with publications in journals like British Journal of Urology International and International Journal of Urology . He has presented at over 100 conferences globally. Key awards include the Board of Urology Frank Gardiner Award (2018), Chris Farrell Prize (2019), and George Schnitzler Award (2021). Dr. Kam’s clinical affiliations include the Nepean Urology Centre and Sydney Urology Associates, where he integrates cutting-edge treatments into patient care. His work emphasizes advancing diagnostic techniques (e.g., PSMA PET/CT, MRI accuracy) and improving outcomes for urological cancers through surgery and technology. Notable contributions include studies on ChatGPT’s role in prostate cancer education, comparative CT imaging techniques, and innovations in lithotripsy. He advocates for minimizing radiation exposure and optimizing surgical tools, as seen in his work on single-use ureteroscopes and laser settings.

• Urology
• Prostate Cancer
• Telemedicine
• +۷ مورد دیگر

Professor Mohamed Khadra is a Professor of Surgery at the University of Sydney's Sydney Medical School. He holds leadership roles as Clinical Director of Surgery and Anaesthetics, and Director of Strategy and Innovation at Nepean Blue Mountains Local Health District. He also chairs the Nepean Telehealth Technology Centre and is Senior Faculty at the Cognitive Institute Pty Ltd. His research focuses on urology, prostate cancer, telemedicine, and surgical leadership. Key contributions include translational research, male incontinence management, and surgical education. He has authored books such as *Making the Cut: A Surgeon's Stories Of Life On The Edge* and *Honour, Duty and Courage*. Prof. Khadra's awards include the Officer of the Order of Australia (2017) and the Sydney University Alumni Medal (2015). He has led major initiatives like the Nepean Telehealth Technology Centre and contributed to national healthcare committees. Grants include the 2013 ATVRE grant for virtual rehabilitation engineering. His work spans surgical training, telehealth innovation, and prostate cancer imaging advancements.

• Cardiovascular Physiology
• Vascular Biology
• Autonomic Neuroscience
• +۵ مورد دیگر

Professor Craig Daly holds the position of Professor of Physiology in the School of Cardiovascular & Metabolic Health at the University of Glasgow. He has been affiliated with the university since 1980, progressing through roles such as research technician, research fellow, and lecturer before achieving his current academic rank. His research focuses on vascular physiology, autonomic nervous system regulation of blood vessels, and the integration of advanced imaging and VR technologies into medical education and research. Education: Completed MSc and PhD in Medicine through the University of Glasgow's Faculty of Medicine. Awarded a Senior Fellowship of the Higher Education Academy in 2017. Research Interests: Specializes in vascular structure/function, adrenergic receptor distribution, and the application of confocal microscopy, 3D imaging, and virtual reality for biomedical visualization and education. Recent work includes developing mixed-reality tools for medical training and VR-based anatomical models. Publications: Over 150 peer-reviewed articles since 1985, emphasizing vascular biology, pharmacology, and innovative teaching methodologies. Recent trends include VR/AR applications in education, molecular dynamics of receptors, and biomedical visualization techniques. Awards: Recognized for contributions to education with the 2017 Higher Education Academy Senior Fellowship. Labs/Teams: Active in research groups such as Cellular Signalling & Mechanisms and Vascular Structure & Function. Collaborates on projects involving medical animation, drug-receptor interactions, and technology-driven learning solutions.

Danny Manorمشاهده پروفایل

استاد

• Signal Transduction
• Oncology
• Nutrition
• +۶ مورد دیگر

Roles & Affiliations: Danny Manor is a Professor in the Departments of Nutrition and Pharmacology at Case Western Reserve University School of Medicine, and serves as Vice Chair of the Department of Nutrition. He holds additional roles as a Member of the Molecular Oncology Program at the Case Comprehensive Cancer Center. Education: Ph.D. in Anatomy, Structural Biology & Biophysics from Albert Einstein College of Medicine (1989); B.Sc. in Biochemistry from Tel Aviv University (1982). Research Focus: Dr. Manor’s research centers on growth factor signaling pathways, particularly those involving Rho GTPases and Dbl family guanine nucleotide exchange factors (GEFs). His work explores the molecular mechanisms underlying aberrant cell functions in cancer and other diseases. A major emphasis is on vitamin E’s role in health and disease, including its effects on reactive oxygen species, neurodegeneration, and metabolic disorders. His interdisciplinary approach integrates molecular/cell biology, biophysics, synthetic chemistry, and microscopy, with translational collaborations in clinical research. Grants & Funding: Recent grants include NIH/NCI R21 CA254968 (2021–2023) for targeting Tiam1 in cancer and NIH/NIDDK R01 DK125115 (2021–2026) investigating vitamin E and the tocopherol transfer protein. Labs & Teams: Leads the Manor Lab, which focuses on signal transduction, vitamin E mechanisms, and cancer biology. Collaborates with epidemiologists, geneticists, and clinicians to bridge basic and translational research.

• Health Communication
• Cyberbullying Prevention
• Public Health Campaigns
• +۳ مورد دیگر

Matthew W. Savage is an Associate Professor at the School of Communication, San Diego State University (SDSU), specializing in health and interpersonal communication. His research focuses on adolescent bullying/cyberbullying, oral health promotion, and reciprocal violence, emphasizing team science and community partnerships with educational, governmental, and non-profit organizations. He holds a Ph.D. from Arizona State University (2012) and has taught at institutions including the University of Kentucky, University of Hawaii, and Arizona State University, where he received prestigious university teaching awards. His courses include Quantitative Methods in Communication, Health Communication and Relationships, and seminars in Health Communication and Research Methods. Dr. Savage's research integrates behavioral health interventions, public health campaigns, and technology-based solutions to address risky behaviors among adolescents and young adults. Notable projects include cyberbullying prevention strategies, oral health initiatives in Appalachia, and pandemic-related health behavior studies during the COVID-19 crisis. His work has been supported by external and internal funding mechanisms, translating academic research into clinical practice. He actively explores how communication strategies impact policy compliance, vaccine sentiment, and media framing of health issues such as intimate partner violence.

• Urologic Oncology
• Biomarker Development
• Clinical Trial Design
• +۳ مورد دیگر

Fed Ghali, MD, is an Assistant Professor of Urology at the Yale School of Medicine, specializing in urologic oncology with expertise in bladder, ureter, kidney, and testicular cancers. He holds affiliations with Yale Cancer Center, Prostate & Urologic Cancers Program, and Urologic Oncology at Yale School of Medicine. Ghali completed his medical degree at Geisel School of Medicine, residency in Urology at UC San Diego, and a Society of Urologic Oncology fellowship at the University of Washington. His research focuses on clinical trial design, biomarker development for bladder cancer, and improving patient outcomes through personalized therapy. Notable interests include non-muscle invasive bladder cancer recurrence detection via urinary DNA analysis and optimizing treatment protocols for variant histology cancers. He collaborates with institutions nationally to advance therapeutic strategies and biomarker discovery. Ghali emphasizes patient-centered care, balancing high-volume clinical practice with compassionate individualized treatment. He actively participates in Yale's translational research initiatives and clinical trials to bring cutting-edge therapies to patients. His work highlights the integration of surgical innovation, molecular diagnostics, and clinical research in oncology.

• Drug Delivery Systems
• Biomaterials Engineering
• Tissue Regeneration
• +۳ مورد دیگر

Katie Ryan is a Senior Lecturer in Pharmaceutics at the School of Pharmacy, University College Cork (UCC). She holds a BSc in Pharmacy from Trinity College Dublin (TCD) and a PhD in Pharmaceutics (TCD), with postgraduate qualifications in Quality Improvement (TCD) and Teaching & Learning (UCC). She is a member of the UK & Ireland Controlled Release Society, serving as its President (2017-2020). Education & Professional Roles: BSc (Pharmacy), Trinity College Dublin (2001) MSc (Pharmaceutics), Trinity College Dublin (2007) Postgraduate Diploma in Statistics (2004) MA in Teaching & Learning in Higher Education (UCC, 2010) Research Focus: Her work centers on biomaterial-driven drug delivery systems for ocular, orthopedic, and bone regeneration applications. Key areas include: Sustained drug release via PLGA and hydroxyapatite scaffolds S1P receptor modulation in bone and retinal regeneration Combination therapies for implant-associated infections Bioengineered models for drug screening in metastatic cancers Grants & Funding: PI/co-PI of projects totaling >€1.2M from SFI, Enterprise Ireland, and industry collaborations. Active in the SFI-funded SSPC Centre. Awards & Recognition: Aspiring Leaders Leadership Programme (UCC, 2021) Erasmus Staff Mobility Grants (2021, 2016, 2014, 2012, 2011) Best Oral Prize at Irish Pharmacology Association (2021) Teaching & Outreach: Develops critical thinking curricula for pharmacy students. Leads STEM engagement initiatives in Cork schools, including Visual Thinking Strategies workshops. Chairs UCC's School of Pharmacy Staff-Student Committee. Labs & Collaborations: Collaborates with Harvard University (Prof. David Mooney) and Tyndall National Institute (Prof. Martyn Pemble). Active in the COST Action IMPROVE network and serves on editorial boards for Journal of Pharmaceutical Sciences .

• Mathematical Analysis
• Applied Mathematics
• Optimal Control Theory
• +۳ مورد دیگر

Matteo Fornoni is a Research Fellow at the Department of Mathematical Analysis and Applications, University of Pavia. His research focuses on mathematical models for tumor growth dynamics, optimal control theory, and inverse problems in biomedical applications. He specializes in developing and analyzing partial differential equation-based models for cancer progression and medical imaging applications. Recent work emphasizes personalized tumor forecasting, early tumor state reconstruction, and mathematical analysis of non-local models. His 2023-2025 publications demonstrate expertise in Cahn-Hilliard systems, viscous tumor growth models, and Sobolev space convergence in nonsmooth domains. Key technical contributions include iterative algorithms for prostate cancer reconstruction, maximal regularity analysis for tumor models, and optimal control strategies for biomedical systems. Maintains active collaboration through his research group's activities. Currently affiliated with the University of Pavia's Mathematical Analysis and Applications research group, contributing to both theoretical advancements and applied biomedical modeling challenges.

Paul Kwanمشاهده پروفایل

دانشیار

• Prostate Cancer Research
• Medical Education
• Pathology
• +۶ مورد دیگر

Paul Kwan is an Associate Professor in the Department of Medical Education at Tufts University School of Medicine. He joined Tufts in 1975 after earning his Ph.D. from Clark University and has held various roles, including Research Assistant Professor in Pathology, Integrative Physiology and Pathobiology, and Immunology. He currently teaches full-time and serves as course director for Clinical Anatomy (Tufts University School of Dental Medicine) and Basic Human Pathology (Master’s in Biomedical Sciences Program). Doctor of Philosophy, Clark University (1975) Master of Arts, Clark University (1971) Bachelor of Science, University of Maryland (1966) Dr. Kwan’s research focuses on prostate cancer mechanisms, including androgen receptor dynamics, hormonal influences on neoplasia, and nutritional interventions like curcumin and vitamin E in cardiovascular and metabolic diseases. His work spans animal models, immunohistochemistry, and translational studies. Recent publications highlight curcumin’s role in ameliorating atherosclerosis and steatohepatosis, vitamin E’s impact on macrophage activity in hypercholesterolemic models, and mechanistic studies on prostate cancer progression. These reflect interdisciplinary interests in oncology, medical physiology, and nutritional science. Tufts Teaching with Technology Award (2021) Dean’s Award for Excellence in Basic Science Teaching (2016) He has taught courses such as Medical Histology, Basic Human Pathology, and Clinical Anatomy since the 1980s, with current appointments at Tufts University School of Medicine and School of Dental Medicine. His affiliations also include Tufts Medical Center (1975–2015) as Special and Scientific Staff.

Suneil Jainمشاهده پروفایل

استاد بالینی

• Prostate Cancer
• Radiotherapy
• Radiation Therapy and Drug Combination Studies
• +۴ مورد دیگر

Suneil Jain is a Clinical Professor at Queen's University Belfast's School of Medicine, Dentistry and Biomedical Sciences, with a focus on prostate cancer and advanced radiotherapy. He leads the Belfast Manchester FASTMAN Movember/Prostate Cancer UK Centre of Excellence and has expertise in hypofractionated radiotherapy, biomarkers, and nanotechnology. His research includes clinical trials, translational studies, and collaborations across disciplines. He has secured 12 awards, including fellowships and research distinctions. Jain actively supervises PhD students and publishes extensively on prostate cancer treatment outcomes, radiation toxicity, and therapeutic innovations. His work aligns with UN Sustainable Development Goals related to health and well-being.

Aidan Coleمشاهده پروفایل

مدرس ارشد

• Radiation Therapy
• Prostate Cancer
• Radiobiology
• +۵ مورد دیگر

Dr Aidan Cole is a Clinical Senior Lecturer at Queen's University Belfast's School of Medicine, Dentistry, and Biomedical Sciences. He is a key member of the Patrick G Johnston Centre for Cancer Research and actively involved in clinical academic research focusing on prostate cancer treatment, radiobiology, and radiation oncology. His work combines medical physics, radiation biology, and clinical practice to improve patient outcomes. Education: PhD in Radiobiology from Queen's University Belfast (2014). Awards include the ESTRO Accuray Award (2013), St. Lukes Medal (2016), and the Belfast Trust Chairman's Award (2024). He has been shortlisted for the QUB Staff Excellence Awards (Innovation category) and received recognition for research culture contributions. Research Interests: Radiobiology of targeted radionuclides (e.g., Radium-223), stereotactic radiotherapy, immunotherapy, and radiation-induced cardiotoxicity. His group explores biomarkers for radiosensitivity, cardiac toxicity mitigation, and precision radiation oncology. Publications include studies on OSCE assessment authenticity, biomarker development for prostate cancer, and radiation toxicity in lung cancer patients. He has led clinical trials such as the SPORT and TRAP trials, advancing SBRT/SABR protocols for oligometastatic disease. Grants: Active projects include Movember Centre of Excellence (Movember COE) and Clinical Research Fellowship in Radiotherapy. He supervises postgraduate research in imaging biomarkers and radium-223 applications. Labs/Teams: Principal investigator at the Patrick G Johnston Centre for Cancer Research. Collaborates internationally on radiation oncology and translational cancer research.

• Medical Oncology
• Prostate Cancer
• Castration Resistant Prostate Cancer
• +۷ مورد دیگر

Paul Hamberg is affiliated with Erasmus MC in the field of Medical Oncology, where he conducts active research in prostate cancer and related urological malignancies. His work is centered on clinical and translational oncology, with a strong focus on biomarker development and treatment response prediction. Institution: Erasmus MC Division: Medical Oncology His research interests include prostate cancer, castration-resistant prostate cancer, pharmacokinetics, precision medicine, and immune checkpoint inhibitors. He investigates novel biomarkers such as cell-free DNA aneuploidy scores and T-cell-to-stroma enrichment (TSE) to predict therapeutic outcomes. His work also explores advanced imaging techniques like PSMA PET/CT for cancer management. The recent articles highlight a strong trend toward personalized oncology, integrating molecular profiling, metabolic insights, and innovative trial designs. His publications span high-impact journals such as Nature Communications and Molecular Oncology , reflecting a multidisciplinary approach that bridges clinical practice and research. While no specific scientific awards are listed in the provided text, his extensive publication record and collaborative research indicate significant recognition in the oncology community. Paul Hamberg has contributed to the supervision of at least one research work, as indicated by the 'Supervised Work (1)' mention. His involvement in multiple clinical trials and collaborative studies demonstrates active engagement in research mentoring and team science. There is no mention of specific grants, but his participation in complex trials suggests involvement in funded research initiatives. He is part of a robust research network at Erasmus MC, collaborating with experts in urology, nuclear medicine, and molecular oncology. His work is embedded in multidisciplinary teams focused on improving outcomes in prostate and renal cancers.

• Urology
• Urooncology
• Endourology
• +۳ مورد دیگر

Yılmaz Aslan is a Professor and Head of the Department of Urology at Üsküdar University Faculty of Medicine. He obtained his MD from Çukurova University Faculty of Medicine in 1999 and completed his urology residency at Ankara Numune Education and Research Hospital in 2005. He holds expertise in urology, urooncology, endourology, andrology, and BPH management. His career includes international collaborations, including a fellowship at Jikei University in Japan and a decade of surgical initiatives across Balkans, Africa, and Central Asia under the Turkish Ministry of Health. Education: Bachelor of Medicine: Çukurova University Faculty of Medicine (1999) Urology Specialty Training: Ankara Numune Education and Research Hospital (2005) Fellowship: Jikei University School of Medicine, Tokyo (2009) under Prof. Shin Egawa Research Interests: Focus on minimally invasive urological surgeries, adrenal gland disorders, retrograde intrarenal surgery (RIRS), and outcomes of testis-sparing surgeries. His work emphasizes surgical innovation, antibiotic prophylaxis in transurethral procedures, and interdisciplinary approaches to complex cases. Publications & Awards: Over 60 international indexed articles, 40 national publications, and 7 awards. His top studies address adrenal surgery techniques, Fournier gangrene prognosis, and comparative outcomes between robotic and laparoscopic procedures. Administration & Grants: Current Head of Urology since 2022. Active in professional associations and has supervised numerous multicenter studies. Research interests include adrenal incidentalomas, prostate cancer detection post-prostatectomy, and sexual function post-surgery rehabilitation. Labs/Teams: Coordinates international collaborations through the Eurasian Uro-Oncology Association, focusing on testicular mass management and surgical innovations.

Peter Heathcoteمشاهده پروفایل

استاد

• Photosynthetic Reaction Centres
• Protein Cofactor Interactions
• Respiratory Chain Complexes
• +۲ مورد دیگر

Peter Heathcote is Professor of Biochemistry and Co-Director of the Nanchang Joint Programme at Queen Mary University of London's School of Biological and Behavioural Sciences. His research focuses on biochemical mechanisms in photosynthesis and enzymatic systems, with expertise in spectroscopic analysis of protein-cofactor interactions. Research Interests: Heathcote investigates electron transfer pathways in photosynthetic reaction centres (Type I), respiratory complexes, and tetrapyrrole biosynthesis enzymes. His work employs advanced spectroscopic techniques to study redox cofactors and energy transfer in biological systems. Publication Trends: Recent publications bifurcate into two domains: (1) Continued biophysics research on photoexcitation and spectroscopy techniques, and (2) Clinical prostate cancer studies addressing diagnostic imaging (PSMA PET/MRI), surgical outcomes (robotic prostatectomy), and quality-of-life metrics. This reflects interdisciplinary engagement with medical applications. Awards & Advising: No awards or supervised students are documented in available materials.